Investing in gender equity in health and biomedical research: a Singapore perspective

Elsevier, The Lancet, Volume 393, Issue 10171, 9–15 February 2019, Pages 21-22.
Joanne Yoong, Sylvie Alonso, Ching Wan Chan, Marie-Veronique, Clement Lima and Sophia Archuleta

Singapore ranks first in the world in progress towards the health-related Sustainable Development Goals and often highest among Asian countries on measures of innovation and research. This efficient progress is because of Singapore's substantial strategic investments in the past 3 decades, which were aimed at prioritising leadership in health and biomedical research within Asia, and ultimately becoming leaders in global health. The success of this vision rests crucially on human capital—first, shaping a health-care workforce, ready for the future, to support the increasing (and increasingly complex) needs of an ageing population; and second, growing local capacity while attracting international talent to jointly fuel the intellectual core of an aspiring global research hub.